Mark Borodkin's most recent trade in Bionano Genomics Inc was a trade of 27 Common Stock done at an average price of $3.7 . Disclosure was reported to the exchange on June 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bionano Genomics Inc | Mark Borodkin | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.70 per share. | 03 Jun 2025 | 27 | 974 (0%) | 0% | 3.7 | 100 | Common Stock |
| Bionano Genomics Inc | Mark Borodkin | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2025 | 6,966 | 6,966 | - | - | Stock Option (Right to Buy) | |
| Bionano Genomics Inc | Mark Borodkin | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.75 per share. | 15 Feb 2025 | 20 | 1,001 (0%) | 0% | 5.8 | 115 | Common Stock |
| Bionano Genomics Inc | Mark Borodkin | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.48 per share. | 11 Sep 2024 | 3,568 | 61,283 (0%) | 0% | 0.5 | 1,713 | Common Stock |
| Bionano Genomics Inc | Mark Borodkin | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Bionano Genomics Inc | Mark Borodkin | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 16,000 | 64,698 (0%) | 0% | 0 | Common Stock | |
| Bionano Genomics Inc | Mark Borodkin | CHIEF OPERATING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.27 per share. | 15 Feb 2024 | 1,229 | 48,644 (0%) | 0% | 1.3 | 1,561 | Common Stock |
| Bionano Genomics Inc | Mark Borodkin | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.66 per share. | 12 May 2023 | 41,496 | 297,842 (0%) | 0% | 0.7 | 27,387 | Common Stock |
| Bionano Genomics Inc | Mark Borodkin | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 560,000 | 560,000 | - | - | Stock Option (Right to Buy) | |
| Bionano Genomics Inc | Mark Borodkin | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 120,000 | 339,338 (0%) | 0% | 0 | Common Stock | |
| Bionano Genomics Inc | Mark Borodkin | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.41 per share. | 12 May 2022 | 41,496 | 216,669 (0%) | 0% | 1.4 | 58,509 | Common Stock |
| Bionano Genomics Inc | Mark Borodkin | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 650,000 | 650,000 | - | - | Stock Option (Right to Buy) | |
| Bionano Genomics Inc | Mark Borodkin | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 240,000 | 252,086 (0%) | 0% | 0 | Common Stock | |
| Bionano Genomics Inc | Mark Borodkin | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 275,000 | 275,000 | - | - | Stock Option (Right to Buy) |